Search results
Results From The WOW.Com Content Network
Management Algorithm for Adults with Hyperkalemia (K> 5.5 mEq/L) *All disposition and treatment recommendations should account for local standards of care and should not supersede the clinical judgement of the treating physician. Recommended Doses for Acute Care Settings: Calcium Gluconate: 1 gram; Calcium Chloride: 1 ampule.
There is a need to improve effective management of hyperkalemia, including classification and K + monitoring, when to reinitiate previously discontinued renin-angiotensin-aldosterone system inhibitor (RAASi) therapy, and when to use oral K + -binding agents.
Hyperkalemia is a common clinical problem that is most often a result of impaired urinary potassium excretion due to acute or chronic kidney disease (CKD) and/or disorders or drugs that inhibit the renin-angiotensin-aldosterone system (RAAS).
Once hyperkalemia is diagnosed, the primary condition must be treated. Patients with hyperkalemia need cardiac monitoring, and nurses should be familiar with ECG features of hyperkalemia, which are often the first to appear.
Hyperkalemia is a common clinical problem that is most often a result of impaired urinary potassium excretion due to acute or chronic kidney disease (CKD) and/or disorders or drugs that inhibit the renin-angiotensin-aldosterone system (RAAS). Therapy for hyperkalemia due to potassium retention is ultimately aimed at inducing potassium loss [1-3 ...
This article summarizes information on available therapies for hyperkalemia and proposes a hyperkalemia treatment algorithm for the ED practitioner based on the currently available literature and highlights diagnostic pitfalls and evidence gaps.
An unmet need exists for new hyperkalemia management guidelines that effectively incorporate classification and moni-toring for hyperkalemia, optimization of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy, and use of the newer potassium (Kþ) binders.